OFS Capital Q2: Net Investment Income Halves, NAV Rises on Equity Gains
OFS sits 19% above its 52-week low of $2.716 on elevated volume (2.3× avg).
Summary
OFS Capital's Q2 2026 net investment income fell sharply to $0.08 per share, but NAV rose to $8.41 on equity gains. Non-accrual loans increased, and the company reduced debt.
Key Events · Earnings and Guidance · OFS
-
Net Investment Income Halves
Q2 2026 net investment income was $0.08 per share, down from $0.18 in Q1 2026, driven by lower interest income and the absence of a $0.9 million non-recurring dividend from Pfanstiehl.
-
NAV Rises on Equity Gains
NAV per share increased to $8.41 from $8.16 at March 31, 2026, primarily due to a $14.1 million unrealized gain on the Pfanstiehl Holdings common equity investment.
-
Non-Accrual Loans Increase
Non-accrual loans rose to $21.4 million at fair value (7.2% of total investments), up from $14.4 million at year-end 2025, with One GI LLC placed on non-accrual during the quarter.
-
Debt Reduced, Coverage Improves
Total outstanding debt decreased by $16.7 million to $185.8 million, improving the asset coverage ratio to 161% from 150% minimum required.
Analysis · OFS · Unknown
OFS Capital's Q2 2026 net investment income dropped to $0.08 per share from $0.18 in Q1, driven by lower interest income and a non-recurring dividend in the prior quarter. NAV per share increased to $8.41, buoyed by a $14.1 million unrealized gain on its Pfanstiehl equity stake. Non-accrual loans now represent 7.2% of the portfolio at fair value, up from 4.2% at year-end, signaling credit deterioration. The company reduced total debt by $16.7 million during the quarter, improving its asset coverage ratio to 161%. The results highlight a bifurcation: core earnings are under pressure from declining portfolio yields and rising non-accruals, while equity holdings provide a valuation cushion.
At the time of this filing, OFS was trading at $3.23 on NASDAQ in the Unknown sector, with a market capitalization of approximately $44.1M. The 52-week trading range was $2.72 to $8.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.